Vascular Embolization Agent - Global and China Top Players Market Share and Ranking 2023
According to Latest Research, the global market for Vascular Embolization Agent should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Vascular Embolization Agent market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Vascular Embolization Agent market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Ambulatory Surgery Center grew percent.
This report studies and analyses global Vascular Embolization Agent status and future trends, helps the client to determine the Vascular Embolization Agent market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Vascular Embolization Agent, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Vascular Embolization Agent market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Vascular Embolization Agent sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Vascular Embolization Agent sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Vascular Embolization Agent key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Vascular Embolization Agent key producing regions, capacity, production, and year over year growth
(6) Vascular Embolization Agent industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Abbott
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
SSEM Mthembu Medical (Pty) Ltd
Balt USA LLC
Stryker
Guerbet LLC
Terumo Corporation
Penumbra
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Jiangsu Hengrui Medicine
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
Market segment by Type, covers
Temporary
Permanent
Market segment by Application, can be divided into
Hospital
Ambulatory Surgery Center
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Vascular Embolization Agent product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Vascular Embolization Agent market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Vascular Embolization Agent market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Vascular Embolization Agent, percent & CAGR, 2018-2029
Chapter 5: Vascular Embolization Agent industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Vascular Embolization Agent Definition
1.2 Global Vascular Embolization Agent Market Size and Forecast
1.2.1 By Consumption Value, Global Vascular Embolization Agent Market Size，2018-2029
1.2.2 By Sales Quantity, Global Vascular Embolization Agent Market Size，2018-2029
1.2.3 Global Vascular Embolization Agent Average Selling Price (ASP)，2018-2029
1.3 China Vascular Embolization Agent Market Size and Forecast
1.3.1 By Consumption Value, China Vascular Embolization Agent Market Size，2018-2029
1.3.2 By Sales Quantity, China Vascular Embolization Agent Market Size，2018-2029
1.3.3 China Vascular Embolization Agent Average Selling Price (ASP)， 2018-2029
1.4 Share of China Vascular Embolization Agent Market with Respect to the Global Market
1.4.1 By Consumption Value, China Vascular Embolization Agent Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Vascular Embolization Agent Market Share in Global, 2018-2029
1.4.3 Vascular Embolization Agent Market Size: China VS Global, 2018-2029
1.5 Vascular Embolization Agent Market Dynamics
1.5.1 Vascular Embolization Agent Market Drivers
1.5.2 Vascular Embolization Agent Market Restraints
1.5.3 Vascular Embolization Agent Industry Trends
1.5.4 Vascular Embolization Agent Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Vascular Embolization Agent, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Vascular Embolization Agent, Global Market Share by Company, 2018-2023
2.3 Vascular Embolization Agent Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Vascular Embolization Agent Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Vascular Embolization Agent Concentration Ratio
2.6 Global Vascular Embolization Agent Mergers & Acquisitions, Expansion Plans
2.7 Global Vascular Embolization Agent Manufacturers Product Type
2.8 Head Office and Vascular Embolization Agent Production Site of Key Manufacturer
2.9 Vascular Embolization Agent Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Vascular Embolization Agent, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Vascular Embolization Agent, China Market Share by Company, 2018-2023
3.3 China Vascular Embolization Agent Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Vascular Embolization Agent Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Vascular Embolization Agent Capacity by Region
4.3 Global Vascular Embolization Agent Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Vascular Embolization Agent Production by Region, 2018-2029
4.5 Global Vascular Embolization Agent Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Vascular Embolization Agent Industry Chain
5.2 Vascular Embolization Agent Upstream Analysis
5.2.1 Vascular Embolization Agent Core Raw Materials
5.2.2 Main Manufacturers of Vascular Embolization Agent Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Vascular Embolization Agent Production Mode
5.6 Vascular Embolization Agent Procurement Model
5.7 Vascular Embolization Agent Industry Sales Model and Sales Channels
5.7.1 Vascular Embolization Agent Sales Model
5.7.2 Vascular Embolization Agent Typical Distributors
6 Sights by Type
6.1 Vascular Embolization Agent Classification
6.1.1 Temporary
6.1.2 Permanent
6.2 By Type, Global Vascular Embolization Agent Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Vascular Embolization Agent Consumption Value, 2018-2029
6.4 By Type, Global Vascular Embolization Agent Sales Quantity, 2018-2029
6.5 By Type, Global Vascular Embolization Agent Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Vascular Embolization Agent Segment by Application
7.1.1 Hospital
7.1.2 Ambulatory Surgery Center
7.2 By Application, Global Vascular Embolization Agent Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Vascular Embolization Agent Consumption Value, 2018-2029
7.4 By Application, Global Vascular Embolization Agent Sales Quantity, 2018-2029
7.5 By Application, Global Vascular Embolization Agent Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Vascular Embolization Agent Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Vascular Embolization Agent Consumption Value, 2018-2029
8.3 By Region, Global Vascular Embolization Agent Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Vascular Embolization Agent & Forecasts, 2018-2029
8.4.2 By Country, North America Vascular Embolization Agent Market Size Market Share
8.5 Europe
8.5.1 Europe Vascular Embolization Agent Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Vascular Embolization Agent Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Vascular Embolization Agent Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Vascular Embolization Agent Market Size Market Share
8.7 South America
8.7.1 South America Vascular Embolization Agent Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Vascular Embolization Agent Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Vascular Embolization Agent Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Vascular Embolization Agent Consumption Value, 2018-2029
9.3 By Country, Global Vascular Embolization Agent Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Vascular Embolization Agent Market Size, 2018-2029
9.4.2 By Type, U.S. Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Vascular Embolization Agent Market Size, 2018-2029
9.5.2 By Type, Europe Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Vascular Embolization Agent Market Size, 2018-2029
9.6.2 By Type, China Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Vascular Embolization Agent Market Size, 2018-2029
9.7.2 By Type, Japan Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Vascular Embolization Agent Market Size, 2018-2029
9.8.2 By Type, South Korea Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Vascular Embolization Agent Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Vascular Embolization Agent Market Size, 2018-2029
9.10.2 By Type, India Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Vascular Embolization Agent Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Vascular Embolization Agent Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abbott
10.1.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.1.2 Abbott Vascular Embolization Agent Models, Specifications, and Application
10.1.3 Abbott Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abbott Company Profile and Main Business
10.1.5 Abbott Recent Developments
10.2 Boston Scientific Corporation
10.2.1 Boston Scientific Corporation Company Information, Head Office, Market Area, and Industry Position
10.2.2 Boston Scientific Corporation Vascular Embolization Agent Models, Specifications, and Application
10.2.3 Boston Scientific Corporation Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Boston Scientific Corporation Company Profile and Main Business
10.2.5 Boston Scientific Corporation Recent Developments
10.3 Cook Medical LLC
10.3.1 Cook Medical LLC Company Information, Head Office, Market Area, and Industry Position
10.3.2 Cook Medical LLC Vascular Embolization Agent Models, Specifications, and Application
10.3.3 Cook Medical LLC Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Cook Medical LLC Company Profile and Main Business
10.3.5 Cook Medical LLC Recent Developments
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.4.2 Johnson & Johnson Vascular Embolization Agent Models, Specifications, and Application
10.4.3 Johnson & Johnson Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Johnson & Johnson Company Profile and Main Business
10.4.5 Johnson & Johnson Recent Developments
10.5 Medtronic
10.5.1 Medtronic Company Information, Head Office, Market Area, and Industry Position
10.5.2 Medtronic Vascular Embolization Agent Models, Specifications, and Application
10.5.3 Medtronic Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Medtronic Company Profile and Main Business
10.5.5 Medtronic Recent Developments
10.6 Acandis GmbH
10.6.1 Acandis GmbH Company Information, Head Office, Market Area, and Industry Position
10.6.2 Acandis GmbH Vascular Embolization Agent Models, Specifications, and Application
10.6.3 Acandis GmbH Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Acandis GmbH Company Profile and Main Business
10.6.5 Acandis GmbH Recent Developments
10.7 SSEM Mthembu Medical (Pty) Ltd
10.7.1 SSEM Mthembu Medical (Pty) Ltd Company Information, Head Office, Market Area, and Industry Position
10.7.2 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Models, Specifications, and Application
10.7.3 SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 SSEM Mthembu Medical (Pty) Ltd Company Profile and Main Business
10.7.5 SSEM Mthembu Medical (Pty) Ltd Recent Developments
10.8 Balt USA LLC
10.8.1 Balt USA LLC Company Information, Head Office, Market Area, and Industry Position
10.8.2 Balt USA LLC Vascular Embolization Agent Models, Specifications, and Application
10.8.3 Balt USA LLC Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Balt USA LLC Company Profile and Main Business
10.8.5 Balt USA LLC Recent Developments
10.9 Stryker
10.9.1 Stryker Company Information, Head Office, Market Area, and Industry Position
10.9.2 Stryker Vascular Embolization Agent Models, Specifications, and Application
10.9.3 Stryker Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Stryker Company Profile and Main Business
10.9.5 Stryker Recent Developments
10.10 Guerbet LLC
10.10.1 Guerbet LLC Company Information, Head Office, Market Area, and Industry Position
10.10.2 Guerbet LLC Vascular Embolization Agent Models, Specifications, and Application
10.10.3 Guerbet LLC Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Guerbet LLC Company Profile and Main Business
10.10.5 Guerbet LLC Recent Developments
10.11 Terumo Corporation
10.11.1 Terumo Corporation Company Information, Head Office, Market Area, and Industry Position
10.11.2 Terumo Corporation Vascular Embolization Agent Models, Specifications, and Application
10.11.3 Terumo Corporation Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Terumo Corporation Company Profile and Main Business
10.11.5 Terumo Corporation Recent Developments
10.12 Penumbra
10.12.1 Penumbra Company Information, Head Office, Market Area, and Industry Position
10.12.2 Penumbra Vascular Embolization Agent Models, Specifications, and Application
10.12.3 Penumbra Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Penumbra Company Profile and Main Business
10.12.5 Penumbra Recent Developments
10.13 Grandpharma (Sirtex)
10.13.1 Grandpharma (Sirtex) Company Information, Head Office, Market Area, and Industry Position
10.13.2 Grandpharma (Sirtex) Vascular Embolization Agent Models, Specifications, and Application
10.13.3 Grandpharma (Sirtex) Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Grandpharma (Sirtex) Company Profile and Main Business
10.13.5 Grandpharma (Sirtex) Recent Developments
10.14 Merit Medical
10.14.1 Merit Medical Company Information, Head Office, Market Area, and Industry Position
10.14.2 Merit Medical Vascular Embolization Agent Models, Specifications, and Application
10.14.3 Merit Medical Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Merit Medical Company Profile and Main Business
10.14.5 Merit Medical Recent Developments
10.15 Siemens Healthineers (Varian)
10.15.1 Siemens Healthineers (Varian) Company Information, Head Office, Market Area, and Industry Position
10.15.2 Siemens Healthineers (Varian) Vascular Embolization Agent Models, Specifications, and Application
10.15.3 Siemens Healthineers (Varian) Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Siemens Healthineers (Varian) Company Profile and Main Business
10.15.5 Siemens Healthineers (Varian) Recent Developments
10.16 Jiangsu Hengrui Medicine
10.16.1 Jiangsu Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
10.16.2 Jiangsu Hengrui Medicine Vascular Embolization Agent Models, Specifications, and Application
10.16.3 Jiangsu Hengrui Medicine Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Jiangsu Hengrui Medicine Company Profile and Main Business
10.16.5 Jiangsu Hengrui Medicine Recent Developments
10.17 Kaneka
10.17.1 Kaneka Company Information, Head Office, Market Area, and Industry Position
10.17.2 Kaneka Vascular Embolization Agent Models, Specifications, and Application
10.17.3 Kaneka Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Kaneka Company Profile and Main Business
10.17.5 Kaneka Recent Developments
10.18 Meril Life Sciences
10.18.1 Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.18.2 Meril Life Sciences Vascular Embolization Agent Models, Specifications, and Application
10.18.3 Meril Life Sciences Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.18.4 Meril Life Sciences Company Profile and Main Business
10.18.5 Meril Life Sciences Recent Developments
10.19 Peijia Medical
10.19.1 Peijia Medical Company Information, Head Office, Market Area, and Industry Position
10.19.2 Peijia Medical Vascular Embolization Agent Models, Specifications, and Application
10.19.3 Peijia Medical Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.19.4 Peijia Medical Company Profile and Main Business
10.19.5 Peijia Medical Recent Developments
10.20 Wallaby Medical
10.20.1 Wallaby Medical Company Information, Head Office, Market Area, and Industry Position
10.20.2 Wallaby Medical Vascular Embolization Agent Models, Specifications, and Application
10.20.3 Wallaby Medical Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.20.4 Wallaby Medical Company Profile and Main Business
10.20.5 Wallaby Medical Recent Developments
10.21 MicroPort Scientific Corporation
10.21.1 MicroPort Scientific Corporation Company Information, Head Office, Market Area, and Industry Position
10.21.2 MicroPort Scientific Corporation Vascular Embolization Agent Models, Specifications, and Application
10.21.3 MicroPort Scientific Corporation Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.21.4 MicroPort Scientific Corporation Company Profile and Main Business
10.21.5 MicroPort Scientific Corporation Recent Developments
10.22 Weihai Visee Medical Devices
10.22.1 Weihai Visee Medical Devices Company Information, Head Office, Market Area, and Industry Position
10.22.2 Weihai Visee Medical Devices Vascular Embolization Agent Models, Specifications, and Application
10.22.3 Weihai Visee Medical Devices Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.22.4 Weihai Visee Medical Devices Company Profile and Main Business
10.22.5 Weihai Visee Medical Devices Recent Developments
10.23 Beijing Taijieweiye Technology
10.23.1 Beijing Taijieweiye Technology Company Information, Head Office, Market Area, and Industry Position
10.23.2 Beijing Taijieweiye Technology Vascular Embolization Agent Models, Specifications, and Application
10.23.3 Beijing Taijieweiye Technology Vascular Embolization Agent Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.23.4 Beijing Taijieweiye Technology Company Profile and Main Business
10.23.5 Beijing Taijieweiye Technology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Vascular Embolization Agent Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Vascular Embolization Agent Market Restraints
Table 3. Vascular Embolization Agent Market Trends
Table 4. Vascular Embolization Agent Industry Policy
Table 5. Global Vascular Embolization Agent Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Vascular Embolization Agent Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Vascular Embolization Agent Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Vascular Embolization Agent Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Vascular Embolization Agent Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Vascular Embolization Agent Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Vascular Embolization Agent Mergers & Acquisitions, Expansion Plans
Table 12. Global Vascular Embolization Agent Manufacturers Product Type
Table 13. Head Office and Vascular Embolization Agent Production Site of Key Manufacturer
Table 14. Vascular Embolization Agent Capacity of Major Manufacturers and Future Plan
Table 15. China Vascular Embolization Agent Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Vascular Embolization Agent Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Vascular Embolization Agent Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Vascular Embolization Agent Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Vascular Embolization Agent Production by Region, 2018-2023, (K Units)
Table 20. Global Vascular Embolization Agent Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Vascular Embolization Agent Upstream (Raw Materials)
Table 22. Global Vascular Embolization Agent Typical Customers
Table 23. Vascular Embolization Agent Typical Distributors
Table 24. By Type, Global Vascular Embolization Agent Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Vascular Embolization Agent Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Vascular Embolization Agent Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Vascular Embolization Agent Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Vascular Embolization Agent Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Vascular Embolization Agent Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Vascular Embolization Agent Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Vascular Embolization Agent Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Vascular Embolization Agent Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Vascular Embolization Agent Sales Quantity Market Share, 2018-2029
Table 34. Abbott Company Information, Head Office, Market Area, and Industry Position
Table 35. Abbott Vascular Embolization Agent Models, Specifications, and Application
Table 36. Abbott Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Abbott Company Profile and Main Business
Table 38. Abbott Recent Developments
Table 39. Boston Scientific Corporation Company Information, Head Office, Market Area, and Industry Position
Table 40. Boston Scientific Corporation Vascular Embolization Agent Models, Specifications, and Application
Table 41. Boston Scientific Corporation Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Boston Scientific Corporation Company Profile and Main Business
Table 43. Boston Scientific Corporation Recent Developments
Table 44. Cook Medical LLC Company Information, Head Office, Market Area, and Industry Position
Table 45. Cook Medical LLC Vascular Embolization Agent Models, Specifications, and Application
Table 46. Cook Medical LLC Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Cook Medical LLC Company Profile and Main Business
Table 48. Cook Medical LLC Recent Developments
Table 49. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 50. Johnson & Johnson Vascular Embolization Agent Models, Specifications, and Application
Table 51. Johnson & Johnson Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Johnson & Johnson Company Profile and Main Business
Table 53. Johnson & Johnson Recent Developments
Table 54. Medtronic Company Information, Head Office, Market Area, and Industry Position
Table 55. Medtronic Vascular Embolization Agent Models, Specifications, and Application
Table 56. Medtronic Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Medtronic Company Profile and Main Business
Table 58. Medtronic Recent Developments
Table 59. Acandis GmbH Company Information, Head Office, Market Area, and Industry Position
Table 60. Acandis GmbH Vascular Embolization Agent Models, Specifications, and Application
Table 61. Acandis GmbH Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Acandis GmbH Company Profile and Main Business
Table 63. Acandis GmbH Recent Developments
Table 64. SSEM Mthembu Medical (Pty) Ltd Company Information, Head Office, Market Area, and Industry Position
Table 65. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Models, Specifications, and Application
Table 66. SSEM Mthembu Medical (Pty) Ltd Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. SSEM Mthembu Medical (Pty) Ltd Company Profile and Main Business
Table 68. SSEM Mthembu Medical (Pty) Ltd Recent Developments
Table 69. Balt USA LLC Company Information, Head Office, Market Area, and Industry Position
Table 70. Balt USA LLC Vascular Embolization Agent Models, Specifications, and Application
Table 71. Balt USA LLC Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Balt USA LLC Company Profile and Main Business
Table 73. Balt USA LLC Recent Developments
Table 74. Stryker Company Information, Head Office, Market Area, and Industry Position
Table 75. Stryker Vascular Embolization Agent Models, Specifications, and Application
Table 76. Stryker Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Stryker Company Profile and Main Business
Table 78. Stryker Recent Developments
Table 79. Guerbet LLC Company Information, Head Office, Market Area, and Industry Position
Table 80. Guerbet LLC Vascular Embolization Agent Models, Specifications, and Application
Table 81. Guerbet LLC Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Guerbet LLC Company Profile and Main Business
Table 83. Guerbet LLC Recent Developments
Table 84. Terumo Corporation Company Information, Head Office, Market Area, and Industry Position
Table 85. Terumo Corporation Vascular Embolization Agent Models, Specifications, and Application
Table 86. Terumo Corporation Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Terumo Corporation Company Profile and Main Business
Table 88. Terumo Corporation Recent Developments
Table 89. Penumbra Company Information, Head Office, Market Area, and Industry Position
Table 90. Penumbra Vascular Embolization Agent Models, Specifications, and Application
Table 91. Penumbra Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Penumbra Company Profile and Main Business
Table 93. Penumbra Recent Developments
Table 94. Grandpharma (Sirtex) Company Information, Head Office, Market Area, and Industry Position
Table 95. Grandpharma (Sirtex) Vascular Embolization Agent Models, Specifications, and Application
Table 96. Grandpharma (Sirtex) Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Grandpharma (Sirtex) Company Profile and Main Business
Table 98. Grandpharma (Sirtex) Recent Developments
Table 99. Merit Medical Company Information, Head Office, Market Area, and Industry Position
Table 100. Merit Medical Vascular Embolization Agent Models, Specifications, and Application
Table 101. Merit Medical Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Merit Medical Company Profile and Main Business
Table 103. Merit Medical Recent Developments
Table 104. Siemens Healthineers (Varian) Company Information, Head Office, Market Area, and Industry Position
Table 105. Siemens Healthineers (Varian) Vascular Embolization Agent Models, Specifications, and Application
Table 106. Siemens Healthineers (Varian) Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Siemens Healthineers (Varian) Company Profile and Main Business
Table 108. Siemens Healthineers (Varian) Recent Developments
Table 109. Jiangsu Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
Table 110. Jiangsu Hengrui Medicine Vascular Embolization Agent Models, Specifications, and Application
Table 111. Jiangsu Hengrui Medicine Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Jiangsu Hengrui Medicine Company Profile and Main Business
Table 113. Jiangsu Hengrui Medicine Recent Developments
Table 114. Kaneka Company Information, Head Office, Market Area, and Industry Position
Table 115. Kaneka Vascular Embolization Agent Models, Specifications, and Application
Table 116. Kaneka Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Kaneka Company Profile and Main Business
Table 118. Kaneka Recent Developments
Table 119. Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 120. Meril Life Sciences Vascular Embolization Agent Models, Specifications, and Application
Table 121. Meril Life Sciences Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Meril Life Sciences Company Profile and Main Business
Table 123. Meril Life Sciences Recent Developments
Table 124. Peijia Medical Company Information, Head Office, Market Area, and Industry Position
Table 125. Peijia Medical Vascular Embolization Agent Models, Specifications, and Application
Table 126. Peijia Medical Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 127. Peijia Medical Company Profile and Main Business
Table 128. Peijia Medical Recent Developments
Table 129. Wallaby Medical Company Information, Head Office, Market Area, and Industry Position
Table 130. Wallaby Medical Vascular Embolization Agent Models, Specifications, and Application
Table 131. Wallaby Medical Vascular Embolization Agent Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 132. Wallaby Medical Company Profile and Main Business
Table 133. Wallaby Medical Recent Developments
Table 134. MicroPort Scientific Corporation Vascular Embo
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|